Methylprednisolone use in hospitalised COVID-19 patients: a retrospective study.

Nur Fatin Najwa AzemiFarida Hanim IslahudinRahela Ambaras KhanShamin Mohd SaffianLeong Chee Loon

Published in: Journal of pharmaceutical policy and practice (2024)

The use of methylprednisolone weight-based dosing in hospitalised COVID-19 patients should be considered due to the positive outcome associated with lower in-hospital mortality.

Keyphrases

sars cov
high dose
community acquired pneumonia
body mass index
weight loss
physical activity
weight gain
low dose
body weight